Pediatric Bioscience is a privately held clinical laboratory service company that is developing tests to improve and expedite the diagnosis and treatment of children with Autism Spectrum Disorders (ASD). Our first test is based on a novel set of biomarkers exclusively licensed from the M.I.N.D. Institute at UC Davis, and is a simple blood test that will identify a significant sub-group of children with autism and will help these families understand their risk of having another child with ASD.
The incidence of ASD worldwide has increased dramatically in recent years, with the current incidence rate of 1 in 68 live births in the US. More children today will be diagnosed with ASD than diabetes, Down's syndrome, and cancer combined. By enabling much earlier diagnosis, our blood test has the potential to dramatically improve outcomes, resulting in better quality of life for children with ASD and their families.